Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

regenerative medicine

- PMLiVE

Pelage Pharmaceuticals’ alopecia treatment moves forward to phase 3 trial

The news follows positive phase 2a results for the androgenetic alopecia treatment

Innovative Medical Solutions for Postponing and Undoing Age-Related Disease

Aubrey de Grey, Chief Science Officer at SENS Research Foundation, discusses a range of interesting topics surrounding innovative interventions and technologies that could not just postpone, but theoretically reverse, age-related...

Impetus Digital

Innovative Medical Solutions for Postponing and Undoing Age-related Disease

Aubrey de Grey, Chief Science Officer at SENS Research Foundation, explores the concept of using biomedical technology and regenerative medicine to postpone aging-derived debilitation and death. We dive into many questions surrounding...

Impetus Digital

- PMLiVE

Key role for French cluster in regenerative medicine project

Medicen Paris Region will be responsible for long-term impact of the BONE project

- PMLiVE

Astellas sets up regenerative medicine unit

Will spearhead company's efforts in cell-based therapies

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links